Shaukat Ali, MD
Cardiovascular Disease (Cardiology) · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 25 years
- Graduated 2001
Offices
5 locations · Community Foundation Medical Group · 282 clinicians in this group
Hospitals listed: Clovis Community Medical Center · Community Regional Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ali’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A100025 · Current
Licensed to practise in California · since 2007 · expires 2026-12-31 · Bahuddin Zakaria University, Nishtar Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Interventional Cardiology
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$1,542,082
Medicare paid this office $1,542,082 for 1,655 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 299 | $364,775 | $1,216 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 299 | $245,336 | $409 |
| Return visit (30+ min) | 1,232 | $238,171 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 631 | $100,580 | $155 |
| Removal of plaque in arteries of leg | 12 | $83,737 | $5,234 |
See all 49 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 299 | $364,775 | $1,216 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 299 | $245,336 | $409 |
| Return visit (30+ min) | 1,232 | $238,171 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 631 | $100,580 | $155 |
| Removal of plaque in arteries of leg | 12 | $83,737 | $5,234 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 106 | $76,780 | $698 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 110 | $38,814 | $353 |
| New patient visit (45+ min) | 290 | $34,132 | $118 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 413 | $23,694 | $57 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 125 | $23,544 | $188 |
| Ultrasound of both sides of head and neck blood flow | 111 | $16,727 | $149 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 36 | $16,043 | $411 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,140 | $15,830 | $11 |
| Short return visit (20+ min) | 219 | $15,743 | $67 |
| Ultrasound of leg arteries or artery grafts | 72 | $14,498 | $199 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 83 | $12,600 | $152 |
| Long return visit (40+ min) | 72 | $10,335 | $129 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 55 | $10,059 | $183 |
| Replacement of aortic valve through the skin and femoral artery | 15 | $8,404 | $560 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 111 | $8,109 | $37 |
| Injection, regadenoson, 0.1 mg | 347 | $8,039 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $5,415 | $135 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 18 | $4,874 | $271 |
| Injection for imaging of aorta above heart valve with review by radiologist | 147 | $4,048 | $28 |
| New patient visit (60+ min) | 20 | $3,387 | $169 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | $2,860 | $54 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,263 | $206 |
| Ultrasound of heart blood flow, valves and chambers | 55 | $2,253 | $41 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 110 | $2,225 | $20 |
| Ultrasound study of arm and leg arteries | 34 | $2,174 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,145 | $93 |
| Ultrasound of one leg arteries or artery grafts | 13 | $1,856 | $109 |
| Review by radiologist of both arms or legs arteries image | 11 | $1,453 | $132 |
| Ultrasound scan of abdominal aorta | 12 | $1,344 | $112 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,239 | $83 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 12 | $1,115 | $93 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $1,058 | $42 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 55 | $1,036 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 100 | $931 | $9 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $779 | $71 |
| Programming of dual lead pacemaker system | 20 | $713 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 92 | $647 | $6 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $647 | $54 |
| Ultrasound of both sides of head and neck blood flow | 18 | $528 | $29 |
| Ultrasound of heart, follow-up | 22 | $505 | $19 |
| Injection, aminophyllin, up to 250 mg | 56 | $355 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 17 | $205 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 19 | $128 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $70 | $2 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 48 | More than 81% of doctors who do this |
| Leg revascularization (restoring blood flow) | 14 | More than 64% of doctors who do this |
| Varicose vein removal | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of plaque in arteries of leg | 26 | 20 | 20 | – | – | 16 |
| Removal of plaque in artery of leg, initial vessel | 20 | – | – | – | 14 | – |
| Replacement of aortic valve through the skin and femoral artery | – | – | – | – | – | 15 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,655 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 13% · Women 53% · Also on Medicaid 25% · Health risk score 1.46. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 71% · Diabetes 45% · Chronic kidney disease 36% · Heart failure 28% · Atrial fibrillation 22% · Depression 20% · COPD 18% · Cancer 16% · Stroke 10% · Dementia 6%.
The office billed $7,025,134, Medicare allowed $1,988,504 and paid $1,542,082; for 10,161 services of 81 kinds; $8,410 of it was for drugs given in the office and $1,533,672 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,655 | 10,161 | 75 | 1.46 | $7,025,134 | $1,542,082 |
| 2023 | 1,416 | 8,643 | 74 | 1.45 | $6,193,788 | $1,422,448 |
| 2022 | 1,191 | 8,108 | 74 | 1.46 | $5,074,224 | $1,219,036 |
| 2021 | 1,195 | 8,232 | 74 | 1.69 | $5,893,134 | $1,574,952 |
| 2020 | 1,099 | 6,452 | 74 | 1.85 | $4,087,133 | $1,186,981 |
| 2019 | 1,296 | 6,978 | 73 | 2.27 | $2,894,700 | $1,276,861 |
| 2018 | 1,215 | 5,108 | 72 | 2.25 | $1,491,424 | $645,780 |
| 2017 | 1,434 | 4,753 | 73 | 2.50 | $1,285,723 | $492,790 |
| 2016 | 1,562 | 4,856 | 72 | 2.43 | $1,190,135 | $440,994 |
| 2015 | 1,509 | 3,856 | 72 | 2.39 | $767,986 | $274,211 |
| 2014 | 1,363 | 3,465 | 73 | 2.27 | $709,857 | $257,243 |
| 2013 | 968 | 2,537 | 73 | 2.24 | $512,323 | $188,681 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 51 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 279 | $348,425 | $1,244 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 279 | $233,747 | $417 |
| Return visit (30+ min) | 790 | $139,595 | $98 |
| Removal of plaque in artery of leg, initial vessel | 11 | $93,852 | $6,704 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 506 | $84,213 | $162 |
| Injection, regadenoson, 0.1 mg | 313 | $54,849 | None |
| Short return visit (20+ min) | 540 | $42,481 | $65 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 89 | $32,966 | $366 |
| New patient visit (45+ min) | 253 | $29,910 | $118 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 360 | $20,921 | $58 |
| Ultrasound of both sides of head and neck blood flow | 127 | $20,056 | $158 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 26 | $19,087 | $734 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 82 | $16,189 | $195 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 949 | $13,482 | $11 |
| Long return visit (40+ min) | 80 | $11,995 | $139 |
| Ultrasound of leg arteries or artery grafts | 53 | $11,541 | $202 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $11,070 | $443 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 57 | $9,107 | $154 |
| Telephone medical discussion with physician, 11-20 minutes | 116 | $7,968 | $63 |
| New patient visit (60+ min) | 37 | $6,438 | $174 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 87 | $6,304 | $36 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $5,750 | $192 |
| Telephone medical discussion with physician, 21-30 minutes | 51 | $4,841 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 91 | $4,750 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,112 | $141 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,903 | $264 |
| Injection for imaging of aorta above heart valve with review by radiologist | 89 | $2,584 | $29 |
| Ultrasound study of arm and leg arteries | 30 | $2,113 | $70 |
| Ultrasound of one leg arteries or artery grafts | 11 | $1,772 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,650 | $97 |
| Review by radiologist of both arms or legs arteries image | 11 | $1,638 | $136 |
| Ultrasound scan of abdominal aorta | 13 | $1,505 | $116 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 13 | $1,449 | $91 |
| Ultrasound of heart blood flow, valves and chambers | 31 | $1,338 | $43 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 20 | $1,173 | $59 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 49 | $1,079 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $947 | $43 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 91 | $932 | $10 |
| Programming of dual lead pacemaker system | 17 | $701 | $29 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $613 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 26 | $538 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 49 | $529 | $10 |
| Ultrasound of both sides of head and neck blood flow | 17 | $514 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 69 | $494 | $6 |
| Ultrasound of heart, follow-up | 16 | $357 | $20 |
| Injection, aminophyllin, up to 250 mg | 47 | $340 | None |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 15 | $288 | $18 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 16 | $207 | $9 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 15 | $156 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $73 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $42 | $2 |
2022: 41 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 268 | $331,815 | $1,234 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 269 | $223,178 | $413 |
| Return visit (30+ min) | 669 | $110,784 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 490 | $80,263 | $161 |
| Injection, regadenoson, 0.1 mg | 309 | $59,286 | None |
| Short return visit (20+ min) | 472 | $39,193 | $69 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 94 | $35,810 | $381 |
| New patient visit (45+ min) | 266 | $32,237 | $121 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 361 | $20,839 | $58 |
| Ultrasound of both sides of head and neck blood flow | 109 | $18,137 | $165 |
| Telephone medical discussion with physician, 11-20 minutes | 211 | $17,612 | $73 |
| Ultrasound of leg arteries or artery grafts | 82 | $17,324 | $209 |
| Telephone medical discussion with physician, 21-30 minutes | 134 | $15,843 | $97 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 72 | $14,030 | $195 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 85 | $13,603 | $158 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 839 | $12,034 | $11 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 93 | $9,275 | $50 |
| Long return visit (40+ min) | 59 | $8,689 | $140 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $8,129 | $428 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,492 | $157 |
| New patient visit (60+ min) | 33 | $5,440 | $165 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 25 | $4,759 | $190 |
| Injection for imaging of aorta above heart valve with review by radiologist | 76 | $3,090 | $41 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 51 | $2,793 | $55 |
| Ultrasound study of arm and leg arteries | 40 | $2,703 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,918 | $83 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 14 | $1,458 | $104 |
| Ultrasound scan of abdominal aorta | 11 | $1,273 | $116 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 51 | $1,128 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 25 | $1,109 | $44 |
| Programming of dual lead pacemaker system | 18 | $884 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 76 | $771 | $10 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 29 | $623 | $20 |
| Heart rhythm recording of continous external ekg over 8-15 days | 50 | $599 | $12 |
| Ultrasound of heart, follow-up | 20 | $532 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $520 | $21 |
| Ultrasound of both sides of head and neck blood flow | 15 | $472 | $31 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 29 | $376 | $12 |
| Injection, aminophyllin, up to 250 mg | 44 | $316 | None |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $122 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $69 | $3 |
2021: 48 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 324 | $420,974 | $1,295 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 324 | $275,699 | $424 |
| Removal of plaque in arteries of leg | 16 | $146,233 | $7,312 |
| Return visit (30+ min) | 690 | $128,968 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 482 | $83,921 | $167 |
| Injection, regadenoson, 0.1 mg | 342 | $65,366 | None |
| Telephone medical discussion with physician, 21-30 minutes | 263 | $34,701 | $104 |
| New patient visit (45+ min) | 190 | $22,546 | $119 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 367 | $22,027 | $60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 99 | $21,671 | $212 |
| Short return visit (20+ min) | 250 | $19,154 | $67 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $18,753 | $391 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 27 | $14,523 | $454 |
| Ultrasound of both sides of head and neck blood flow | 84 | $14,437 | $172 |
| Ultrasound of leg arteries or artery grafts | 65 | $13,996 | $212 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $13,323 | $157 |
| Telephone medical discussion with physician, 11-20 minutes | 136 | $11,058 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 719 | $10,351 | $11 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 59 | $9,983 | $166 |
| Long return visit (40+ min) | 56 | $8,623 | $149 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 48 | $8,285 | $86 |
| New patient visit (60+ min) | 40 | $7,035 | $176 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 19 | $5,332 | $281 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 88 | $5,149 | $59 |
| Injection for imaging of aorta above heart valve with review by radiologist | 122 | $5,101 | $42 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,620 | $86 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 18 | $3,544 | $197 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $2,993 | $230 |
| Ultrasound of one leg arteries or artery grafts | 18 | $2,452 | $111 |
| Review by radiologist of both arms or legs arteries image | 13 | $2,041 | $146 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 127 | $1,371 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $1,219 | $45 |
| Ultrasound study of arm and leg arteries | 17 | $1,187 | $70 |
| Ultrasound of both sides of head and neck blood flow | 37 | $1,159 | $31 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 45 | $1,046 | $23 |
| Programming of dual lead pacemaker system | 19 | $838 | $25 |
| Ultrasound of heart blood flow, valves and chambers | 18 | $838 | $47 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 13 | $770 | $59 |
| Heart rhythm recording of continous external ekg over 8-15 days | 45 | $600 | $13 |
| Ultrasound of heart, follow-up | 21 | $418 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $396 | $22 |
| Injection, aminophyllin, up to 250 mg | 46 | $306 | None |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 12 | $248 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 21 | $241 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 32 | $198 | $6 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 12 | $152 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 19 | $107 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $63 | $3 |
2020: 43 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 198 | $257,366 | $1,300 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 198 | $164,584 | $416 |
| Removal of plaque in arteries of leg | 15 | $139,042 | $6,952 |
| Return visit (30+ min) | 610 | $95,161 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 396 | $68,668 | $166 |
| Injection, regadenoson, 0.1 mg | 221 | $41,205 | None |
| Short return visit (20+ min) | 405 | $33,065 | $57 |
| New patient visit (45+ min) | 167 | $20,341 | $122 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 49 | $19,650 | $401 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $16,618 | $449 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 77 | $16,138 | $197 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 246 | $14,508 | $58 |
| Ultrasound of both sides of head and neck blood flow | 80 | $13,452 | $168 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $11,455 | $166 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 582 | $9,072 | $13 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 49 | $9,018 | $92 |
| Ultrasound of leg arteries or artery grafts | 39 | $8,793 | $214 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $7,991 | $87 |
| Long return visit (40+ min) | 46 | $5,366 | $112 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 26 | $4,518 | $161 |
| Injection for imaging of aorta above heart valve with review by radiologist | 100 | $4,385 | $43 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $4,133 | $276 |
| New patient visit (60+ min) | 22 | $3,818 | $174 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 56 | $3,244 | $58 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,642 | $240 |
| Ultrasound study of arm and leg arteries | 40 | $2,557 | $64 |
| Review by radiologist of both arms or legs arteries image | 13 | $2,078 | $148 |
| Ultrasound of one leg arteries or artery grafts | 11 | $1,802 | $113 |
| Ultrasound of both sides of head and neck blood flow | 36 | $1,179 | $33 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 99 | $1,076 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $966 | $44 |
| Programming of dual lead pacemaker system | 20 | $889 | $29 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $845 | $60 |
| External ekg recording for more than 48 hours up to 21 days | 30 | $704 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 30 | $694 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 96 | $660 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 24 | $538 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 24 | $502 | $21 |
| Ultrasound of heart, follow-up | 15 | $320 | $21 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 23 | $264 | $11 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 15 | $193 | $9 |
| Injection, aminophyllin, up to 250 mg | 18 | $116 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $37 | $3 |
2019: 46 services
| Removal of plaque in arteries of leg | 22 | $275,699 | $10,604 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 121 | $153,644 | $1,249 |
| Removal of plaque in artery of leg, initial vessel | 14 | $131,815 | $6,591 |
| Return visit (30+ min) | 639 | $99,722 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 412 | $69,751 | $165 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 135 | $54,945 | $407 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 121 | $53,474 | $218 |
| Injection, regadenoson, 0.1 mg | 209 | $38,650 | None |
| Short return visit (20+ min) | 354 | $26,628 | $58 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 135 | $25,951 | $96 |
| Ultrasound of leg arteries or artery grafts | 83 | $20,722 | $216 |
| New patient visit (45+ min) | 160 | $18,938 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $14,596 | $166 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 256 | $14,473 | $56 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 69 | $14,148 | $202 |
| Ultrasound of both sides of head and neck blood flow | 76 | $12,109 | $159 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 687 | $11,086 | $13 |
| Long return visit (40+ min) | 105 | $10,641 | $99 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $10,040 | $418 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 108 | $6,138 | $57 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 19 | $5,360 | $282 |
| Review by radiologist of both arms or legs arteries image | 26 | $4,782 | $149 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 29 | $4,729 | $163 |
| Ultrasound study of arm and leg arteries | 53 | $3,789 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $3,496 | $85 |
| Injection for imaging of aorta above heart valve with review by radiologist | 77 | $3,229 | $42 |
| Review by radiologist of abdominal aorta and both leg arteries image | 17 | $2,361 | $139 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 281 | $2,336 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $2,232 | $44 |
| Ultrasound of one leg arteries or artery grafts | 17 | $2,200 | $116 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $1,898 | $173 |
| Review by radiologist of abdominal aorta image | 16 | $1,696 | $106 |
| Programming of dual lead pacemaker system | 30 | $1,249 | $27 |
| Ultrasound of both sides of head and neck blood flow | 34 | $1,037 | $31 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 15 | $945 | $63 |
| Review by radiologist of additional artery image | 12 | $849 | $71 |
| Return visit (30+ min) | 11 | $672 | $61 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 28 | $617 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 28 | $587 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 56 | $587 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $505 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 31 | $392 | $9 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 12 | $265 | $22 |
| External ekg recording for more than 48 hours up to 21 days | 12 | $256 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $240 | $22 |
| Injection, aminophyllin, up to 250 mg | 14 | $88 | None |
2018: 31 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 101 | $139,106 | $1,377 |
| Return visit (30+ min) | 413 | $62,356 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 323 | $60,623 | $187 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 103 | $47,000 | $456 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 102 | $38,238 | $188 |
| Injection, regadenoson, 0.1 mg | 163 | $28,663 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 104 | $22,019 | $106 |
| New patient visit (45+ min) | 167 | $21,397 | $128 |
| Short return visit (20+ min) | 280 | $20,396 | $65 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 32 | $17,528 | $501 |
| Ultrasound of both sides of head and neck blood flow | 93 | $16,724 | $178 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $16,708 | $186 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 72 | $15,590 | $200 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 204 | $12,784 | $63 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 14 | $8,352 | $597 |
| Ultrasound of leg arteries or artery grafts | 32 | $8,058 | $244 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 410 | $7,311 | $15 |
| Critical care, first 30-74 minutes | 23 | $7,080 | $202 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 95 | $5,568 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $5,445 | $96 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 19 | $4,568 | $240 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 457 | $4,142 | $7 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 21 | $3,992 | $190 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,750 | $313 |
| Injection for imaging of aorta above heart valve with review by radiologist | 57 | $2,693 | $47 |
| Long return visit (40+ min) | 20 | $2,693 | $128 |
| Ultrasound of both sides of head and neck blood flow | 24 | $756 | $32 |
| Programming of dual lead pacemaker system | 16 | $695 | $30 |
| Electrocardiogram (ecg) 2-day continuous | 22 | $563 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 21 | $547 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $40 | $2 |
2017: 34 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 109 | $127,555 | $1,170 |
| Return visit (30+ min) | 355 | $49,570 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 249 | $46,606 | $183 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 109 | $32,302 | $148 |
| Injection, regadenoson, 0.1 mg | 139 | $24,117 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 135 | $22,009 | $163 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 53 | $21,776 | $411 |
| New patient visit (45+ min) | 139 | $16,580 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $15,822 | $85 |
| Ultrasound of both sides of head and neck blood flow | 95 | $14,975 | $158 |
| Short return visit (20+ min) | 181 | $11,911 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 225 | $11,124 | $49 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 56 | $10,662 | $95 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 170 | $10,408 | $61 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 56 | $10,249 | $183 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 18 | $9,575 | $532 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $8,520 | $406 |
| Critical care, first 30-74 minutes | 20 | $6,292 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 574 | $4,945 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 232 | $3,348 | $13 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $2,438 | $188 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 11 | $1,805 | $164 |
| Ultrasound of both sides of head and neck blood flow | 53 | $1,590 | $30 |
| Injection for imaging of aorta above heart valve with review by radiologist | 36 | $1,555 | $42 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $996 | $59 |
| Ultrasound study of arm and leg arteries | 14 | $903 | $65 |
| Programming of dual lead pacemaker system | 12 | $693 | $30 |
| Ultrasound of heart, follow-up | 24 | $475 | $20 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 20 | $440 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 20 | $425 | $21 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $118 | $6 |
| Injection, aminophyllin, up to 250 mg | 13 | $84 | None |
| Infusion, normal saline solution , 1000 cc | 54 | $83 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 29 | $72 | $2 |
2016: 28 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 97 | $112,086 | $1,156 |
| Return visit (30+ min) | 282 | $44,603 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 235 | $44,079 | $183 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 78 | $30,766 | $394 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 98 | $29,940 | $154 |
| Injection, regadenoson, 0.1 mg | 155 | $25,924 | None |
| New patient visit (45+ min) | 124 | $15,654 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $15,094 | $164 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 77 | $14,381 | $93 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 176 | $10,410 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 186 | $9,578 | $51 |
| Short return visit (20+ min) | 152 | $9,535 | $58 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 46 | $9,227 | $196 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 16 | $8,735 | $546 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 905 | $8,344 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $8,173 | $84 |
| Ultrasound of both sides of head and neck blood flow | 43 | $6,583 | $153 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $5,577 | $398 |
| Critical care, first 30-74 minutes | 17 | $3,242 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 210 | $3,018 | $13 |
| Ultrasound of both sides of head and neck blood flow | 64 | $2,011 | $31 |
| Ultrasound study of arm and leg arteries | 21 | $1,445 | $69 |
| Injection for imaging of aorta above heart valve with review by radiologist | 25 | $1,018 | $41 |
| Programming of dual lead pacemaker system | 13 | $637 | $29 |
| Electrocardiogram (ecg) 2-day continuous | 12 | $262 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $261 | $22 |
| Injection, aminophyllin, up to 250 mg | 26 | $168 | None |
| Infusion, normal saline solution , 1000 cc | 98 | $149 | None |
2015: 21 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 115 | $46,954 | $405 |
| Return visit (30+ min) | 274 | $41,246 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $31,265 | $183 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 117 | $26,233 | $111 |
| Injection, regadenoson, 0.1 mg | 114 | $18,839 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 289 | $14,966 | $51 |
| New patient visit (45+ min) | 104 | $13,039 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $11,527 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 869 | $7,770 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 122 | $7,257 | $59 |
| Short return visit (20+ min) | 63 | $4,079 | $60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $3,895 | $185 |
| Ultrasound of both sides of head and neck blood flow | 22 | $3,600 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,631 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 139 | $2,053 | $14 |
| Ultrasound study of arm and leg arteries | 20 | $1,583 | $75 |
| Programming of dual lead pacemaker system | 11 | $713 | $40 |
| Review by radiologist of both arms or legs arteries image | 12 | $624 | $52 |
| Ultrasound of both sides of head and neck blood flow | 18 | $572 | $32 |
| Injection for imaging of aorta above heart valve with review by radiologist | 13 | $515 | $40 |
| Injection, aminophyllin, up to 250 mg | 12 | $69 | None |
2014: 30 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 102 | $41,232 | $404 |
| Return visit (30+ min) | 213 | $30,585 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $30,255 | $180 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 104 | $24,079 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 372 | $19,441 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $18,672 | $162 |
| Injection, regadenoson, 0.1 mg | 80 | $13,234 | None |
| New patient visit (45+ min) | 74 | $9,019 | $122 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $8,218 | $433 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 36 | $7,477 | $208 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 632 | $5,661 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 101 | $5,537 | $55 |
| Short return visit (20+ min) | 79 | $4,684 | $55 |
| New patient visit (30+ min) | 65 | $4,332 | $67 |
| Ultrasound of both sides of head and neck blood flow | 29 | $4,225 | $146 |
| Critical care, first 30-74 minutes | 13 | $2,881 | $169 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 160 | $2,153 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,845 | $84 |
| Ultrasound study of arm and leg arteries | 13 | $961 | $74 |
| Injection for imaging of aorta above heart valve with review by radiologist | 24 | $952 | $40 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $941 | $86 |
| Ultrasound of both sides of head and neck blood flow | 35 | $877 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $847 | $71 |
| Programming of dual lead pacemaker system | 11 | $699 | $44 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $270 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $178 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $166 | $15 |
| Injection, dipyridamole, per 10 mg | 15 | $43 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $31 | $3 |
| Injection, aminophyllin, up to 250 mg | 20 | $28 | None |
2013: 23 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 64 | $27,250 | $419 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 138 | $22,031 | $157 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 323 | $16,212 | $50 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 106 | $15,990 | $149 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 66 | $15,811 | $118 |
| Return visit (30+ min) | 92 | $9,810 | $82 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $9,557 | $434 |
| Short return visit (20+ min) | 118 | $9,331 | $56 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 47 | $9,080 | $193 |
| New patient visit (30+ min) | 100 | $8,100 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $4,858 | $81 |
| Injection, regadenoson, 0.1 mg | 25 | $4,231 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 64 | $3,702 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 374 | $3,173 | $6 |
| Ultrasound of both sides of head and neck blood flow | 20 | $3,095 | $155 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 132 | $2,044 | $14 |
| Ultrasound study of arm and leg arteries | 17 | $1,330 | $74 |
| Injection for imaging of aorta above heart valve with review by radiologist | 20 | $843 | $38 |
| Review by radiologist of abdominal aorta and both leg arteries image | 11 | $749 | $68 |
| Ultrasound of both sides of head and neck blood flow | 34 | $672 | $20 |
| Programming of dual lead pacemaker system | 11 | $515 | $40 |
| Injection, dipyridamole, per 10 mg | 34 | $92 | None |
| Injection, aminophyllin, up to 250 mg | 30 | $26 | None |
Medicaid work
$3,274 in 2024
Medicaid paid $3,274 for 757 billed services this clinician did in 2024, up to 48 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 417 | $1,949 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 69 | $774 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 257 | $551 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 14 | $0 |
| 2024 | 757 | 4 | 48 | $3,274 |
| 2023 | 965 | 7 | 38 | $3,926 |
| 2022 | 594 | 5 | 39 | $1,857 |
| 2021 | 170 | 3 | 17 | $590 |
| 2020 | 252 | 4 | 26 | $1,196 |
| 2019 | 998 | 7 | 45 | $4,474 |
| 2018 | 2,325 | 8 | 109 | $13,956 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 153 | $2,941 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 327 | $470 |
| Return visit (30+ min) | 355 | $323 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 51 | $72 |
| Short return visit (20+ min) | 53 | $65 |
| CARDIOVASCULAR STRESS TEST | 14 | $28 |
| Injection, regadenoson, 0.1 mg | 12 | $28 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 85 | $951 |
| Return visit (30+ min) | 258 | $635 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 226 | $272 |
| CARDIOVASCULAR STRESS TEST | 12 | $0 |
| Short return visit (20+ min) | 13 | $0 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 45 | $426 |
| Return visit (30+ min) | 98 | $113 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 27 | $52 |
2020
| Return visit (30+ min) | 173 | $919 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 31 | $174 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 36 | $103 |
| Short return visit (20+ min) | 12 | $0 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 255 | $1,590 |
| Return visit (30+ min) | 286 | $1,253 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 137 | $928 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 281 | $595 |
| CARDIOVASCULAR STRESS TEST | 13 | $108 |
| New patient visit (45+ min) | 12 | $0 |
| Long return visit (40+ min) | 14 | $0 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,099 | $5,581 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 282 | $4,662 |
| Return visit (30+ min) | 376 | $1,790 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 430 | $993 |
| Injection, regadenoson, 0.1 mg | 14 | $461 |
| Long return visit (40+ min) | 84 | $383 |
| CARDIOVASCULAR STRESS TEST | 27 | $86 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 13 | $0 |
Drugs they prescribed that Part D paid
$1,009,268
Pharmacies billed $1,009,268 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
6,202 generic and 1,028 brand-name prescriptions · $1,009,268 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 376 | $493,833 | $1,313 |
| Repatha Sureclick | 105 | $106,878 | $1,018 |
| Xarelto | 90 | $95,837 | $1,065 |
| Entresto | 68 | $86,030 | $1,265 |
| Metoprolol | 1,320 | $20,405 | $15 |
See all 54 drugs
| Eliquis | 376 | $493,833 | $1,313 |
| Repatha Sureclick | 105 | $106,878 | $1,018 |
| Xarelto | 90 | $95,837 | $1,065 |
| Entresto | 68 | $86,030 | $1,265 |
| Metoprolol | 1,320 | $20,405 | $15 |
| Ozempic | 22 | $20,366 | $926 |
| Brilinta | 13 | $15,546 | $1,196 |
| Nexlizet | 16 | $14,599 | $912 |
| Vascepa | 27 | $11,973 | $443 |
| Jardiance | 11 | $11,942 | $1,086 |
| Clopidogrel | 494 | $7,189 | $15 |
| Atorvastatin | 601 | $6,840 | $11 |
| Ranolazine Er | 58 | $6,776 | $117 |
| Midodrine | 30 | $6,397 | $213 |
| Edarbyclor | 12 | $6,096 | $508 |
| Icosapent Ethyl | 19 | $5,766 | $303 |
| Amiodarone | 77 | $5,540 | $72 |
| Isosorbide Mononitrate Er | 281 | $4,750 | $17 |
| Potassium Chloride | 167 | $4,386 | $26 |
| Rosuvastatin | 263 | $4,027 | $15 |
| Valsartan | 33 | $3,616 | $110 |
| Ezetimibe | 108 | $3,598 | $33 |
| Amlodipine Besylate | 511 | $3,406 | $7 |
| Losartan | 313 | $3,230 | $10 |
| Carvedilol | 269 | $2,933 | $11 |
| Prasugrel | 29 | $2,344 | $81 |
| Lisinopril | 234 | $2,210 | $9 |
| Furosemide | 375 | $2,137 | $6 |
| Nifedipine Er | 23 | $1,326 | $58 |
| Hydralazine | 87 | $1,326 | $15 |
| Klor-Con 10 | 53 | $1,101 | $21 |
| Diltiazem 24hr Er (Cd) | 47 | $1,052 | $22 |
| Spironolactone | 125 | $970 | $8 |
| Bumetanide | 24 | $805 | $34 |
| Losartan-Hydrochlorothiazide | 54 | $785 | $15 |
| Nitroglycerin | 71 | $760 | $11 |
| Diltiazem 24hr Er (La) | 14 | $735 | $53 |
| Irbesartan | 17 | $638 | $38 |
| Olmesartan Medoxomil | 27 | $622 | $23 |
| Hydrochlorothiazide | 131 | $567 | $4 |
| Pantoprazole | 27 | $555 | $21 |
| Enalapril Maleate | 18 | $552 | $31 |
| Digoxin | 30 | $478 | $16 |
| Metoprolol | 83 | $452 | $5 |
| Chlorthalidone | 23 | $449 | $20 |
| Pravastatin | 27 | $372 | $14 |
| Diltiazem | 24 | $326 | $14 |
| Benazepril | 11 | $276 | $25 |
| Lisinopril-Hydrochlorothiazide | 33 | $259 | $8 |
| Klor-Con 8 | 19 | $232 | $12 |
| Felodipine Er | 15 | $140 | $9 |
| Clonidine | 28 | $98 | $4 |
| Atenolol | 22 | $81 | $4 |
| Simvastatin | 13 | $56 | $4 |
Year by year
| 2024 | 7,230 | 1,204 | None | 14% | $1,009,268 |
| 2023 | 5,962 | 918 | None | 15% | $904,019 |
| 2022 | 5,470 | 781 | None | 13% | $626,355 |
| 2021 | 5,174 | 757 | None | 14% | $526,894 |
| 2020 | 5,132 | 687 | 0% (11) | 16% | $461,880 |
| 2019 | 5,743 | 636 | None | 16% | $401,837 |
| 2018 | 3,994 | 442 | 0% (0) | 18% | $251,068 |
| 2017 | 2,895 | 355 | None | 27% | $176,894 |
| 2016 | 2,955 | 357 | None | 22% | $149,085 |
| 2015 | 3,255 | 341 | None | 19% | $125,979 |
| 2014 | 2,655 | 333 | None | 18% | $87,723 |
| 2013 | 1,594 | 235 | None | 23% | $50,500 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Eliquis | 320 | $403,526 | $1,261 |
| Xarelto | 103 | $117,621 | $1,142 |
| Entresto | 42 | $66,100 | $1,574 |
| Repatha Sureclick | 63 | $63,748 | $1,012 |
| Metoprolol | 1,166 | $25,779 | $22 |
| Ozempic | 22 | $21,618 | $983 |
| Vascepa | 38 | $19,954 | $525 |
| Nexlizet | 26 | $18,187 | $699 |
| Brilinta | 14 | $15,081 | $1,077 |
| Ranolazine Er | 64 | $13,445 | $210 |
| Farxiga | 15 | $12,638 | $843 |
| Corlanor | 11 | $10,582 | $962 |
| Atorvastatin | 565 | $8,982 | $16 |
| Praluent | 13 | $7,991 | $615 |
| Prasugrel | 55 | $6,920 | $126 |
| Clopidogrel | 374 | $6,317 | $17 |
| Icosapent Ethyl | 14 | $6,119 | $437 |
| Amlodipine Besylate | 430 | $5,506 | $13 |
| Midodrine | 33 | $5,158 | $156 |
| Isosorbide Mononitrate Er | 208 | $4,069 | $20 |
| Amiodarone | 63 | $3,901 | $62 |
| Losartan | 260 | $3,611 | $14 |
| Ezetimibe | 43 | $3,232 | $75 |
| Potassium Chloride | 111 | $2,919 | $26 |
| Rosuvastatin | 95 | $2,762 | $29 |
| Furosemide | 299 | $2,643 | $9 |
| Carvedilol | 227 | $2,592 | $11 |
| Lisinopril | 184 | $2,473 | $13 |
| Nitroglycerin | 69 | $2,399 | $35 |
| Irbesartan | 17 | $1,749 | $103 |
| Nifedipine Er | 15 | $1,503 | $100 |
| Valsartan | 25 | $1,496 | $60 |
| Valsartan-Hydrochlorothiazide | 14 | $1,428 | $102 |
| Diltiazem 24hr Er (Cd) | 46 | $1,356 | $29 |
| Hydralazine | 73 | $1,287 | $18 |
| Klor-Con 10 | 47 | $1,251 | $27 |
| Pantoprazole | 24 | $1,110 | $46 |
| Bumetanide | 24 | $1,091 | $45 |
| Losartan-Hydrochlorothiazide | 41 | $931 | $23 |
| Spironolactone | 109 | $928 | $9 |
| Digoxin | 28 | $843 | $30 |
| Chlorthalidone | 17 | $759 | $45 |
| Hydrochlorothiazide | 112 | $678 | $6 |
| Metoprolol | 74 | $668 | $9 |
| Fenofibrate | 12 | $468 | $39 |
| Lisinopril-Hydrochlorothiazide | 19 | $444 | $23 |
| Klor-Con 8 | 14 | $410 | $29 |
| Olmesartan Medoxomil | 12 | $395 | $33 |
| Atenolol | 25 | $300 | $12 |
| Simvastatin | 15 | $200 | $13 |
| Clonidine | 20 | $199 | $10 |
| Meclizine | 13 | $194 | $15 |
| Pravastatin | 17 | $175 | $10 |
2022: 45 drugs
| Eliquis | 267 | $285,877 | $1,071 |
| Xarelto | 98 | $90,165 | $920 |
| Entresto | 43 | $54,997 | $1,279 |
| Metoprolol | 1,056 | $20,724 | $20 |
| Brilinta | 22 | $18,041 | $820 |
| Repatha Sureclick | 18 | $14,898 | $828 |
| Vascepa | 30 | $14,468 | $482 |
| Prasugrel | 85 | $9,927 | $117 |
| Nexlizet | 13 | $9,672 | $744 |
| Atorvastatin | 570 | $7,178 | $13 |
| Ranolazine Er | 41 | $6,562 | $160 |
| Farxiga | 11 | $6,433 | $585 |
| Praluent | 13 | $5,930 | $456 |
| Clopidogrel | 370 | $4,723 | $13 |
| Potassium Chloride | 120 | $4,697 | $39 |
| Ezetimibe | 37 | $3,824 | $103 |
| Amlodipine Besylate | 457 | $3,681 | $8 |
| Rosuvastatin | 70 | $3,545 | $51 |
| Midodrine | 28 | $3,260 | $116 |
| Isosorbide Mononitrate Er | 194 | $3,076 | $16 |
| Nitroglycerin | 62 | $2,790 | $45 |
| Carvedilol | 217 | $2,139 | $10 |
| Losartan | 236 | $1,814 | $8 |
| Furosemide | 275 | $1,790 | $7 |
| Lisinopril | 185 | $1,336 | $7 |
| Diltiazem 24hr Er (Cd) | 38 | $1,260 | $33 |
| Valsartan | 25 | $1,241 | $50 |
| Irbesartan | 16 | $1,226 | $77 |
| Hydralazine | 65 | $1,181 | $18 |
| Amiodarone | 44 | $1,060 | $24 |
| Fenofibrate | 16 | $1,030 | $64 |
| Digoxin | 37 | $975 | $26 |
| Metoprolol | 106 | $752 | $7 |
| Nifedipine Er | 13 | $742 | $57 |
| Pantoprazole | 26 | $735 | $28 |
| Klor-Con 10 | 26 | $686 | $26 |
| Spironolactone | 104 | $674 | $6 |
| Chlorthalidone | 13 | $611 | $47 |
| Bumetanide | 12 | $611 | $51 |
| Losartan-Hydrochlorothiazide | 24 | $412 | $17 |
| Hydrochlorothiazide | 92 | $369 | $4 |
| Pravastatin | 19 | $326 | $17 |
| Atenolol | 28 | $226 | $8 |
| Simvastatin | 16 | $206 | $13 |
| Clonidine | 16 | $175 | $11 |
2021: 47 drugs
| Eliquis | 313 | $253,095 | $809 |
| Xarelto | 89 | $63,346 | $712 |
| Brilinta | 56 | $32,445 | $579 |
| Entresto | 21 | $23,230 | $1,106 |
| Repatha Sureclick | 30 | $22,660 | $755 |
| Metoprolol | 954 | $19,116 | $20 |
| Pradaxa | 11 | $12,754 | $1,159 |
| Vascepa | 17 | $10,329 | $608 |
| Prasugrel | 80 | $7,786 | $97 |
| Atorvastatin | 528 | $6,998 | $13 |
| Ranolazine Er | 35 | $6,730 | $192 |
| Clopidogrel | 402 | $5,606 | $14 |
| Praluent | 12 | $5,373 | $448 |
| Potassium Chloride | 64 | $3,096 | $48 |
| Isosorbide Mononitrate Er | 188 | $3,024 | $16 |
| Losartan | 221 | $2,844 | $13 |
| Amlodipine Besylate | 419 | $2,789 | $7 |
| Rosuvastatin | 59 | $2,761 | $47 |
| Carvedilol | 208 | $2,466 | $12 |
| Ezetimibe | 21 | $1,928 | $92 |
| Nitroglycerin | 42 | $1,839 | $44 |
| Midodrine | 25 | $1,741 | $70 |
| Irbesartan | 11 | $1,496 | $136 |
| Lisinopril | 194 | $1,367 | $7 |
| Valsartan-Hydrochlorothiazide | 12 | $1,355 | $113 |
| Valsartan | 15 | $1,329 | $89 |
| Furosemide | 276 | $1,325 | $5 |
| Diltiazem 24hr Er (Cd) | 40 | $1,269 | $32 |
| Spironolactone | 107 | $970 | $9 |
| Hydralazine | 60 | $890 | $15 |
| Amiodarone | 46 | $858 | $19 |
| Metoprolol | 134 | $789 | $6 |
| Nifedipine Er | 12 | $748 | $62 |
| Bumetanide | 15 | $725 | $48 |
| Digoxin | 35 | $686 | $20 |
| Pantoprazole | 27 | $531 | $20 |
| Telmisartan | 13 | $531 | $41 |
| Chlorthalidone | 20 | $437 | $22 |
| Diltiazem 24hr Er | 12 | $384 | $32 |
| Simvastatin | 27 | $278 | $10 |
| Losartan-Hydrochlorothiazide | 22 | $276 | $13 |
| Omeprazole | 12 | $227 | $19 |
| Hydrochlorothiazide | 42 | $210 | $5 |
| Atenolol | 11 | $189 | $17 |
| Warfarin | 11 | $145 | $13 |
| Clonidine | 16 | $108 | $7 |
| Diazepam | 25 | $20 | $1 |
2020: 48 drugs
| Eliquis | 310 | $204,027 | $658 |
| Xarelto | 75 | $61,964 | $826 |
| Brilinta | 91 | $47,366 | $521 |
| Entresto | 17 | $22,762 | $1,339 |
| Metoprolol | 963 | $18,401 | $19 |
| Repatha Sureclick | 23 | $17,040 | $741 |
| Pradaxa | 22 | $14,320 | $651 |
| Ranolazine Er | 34 | $6,910 | $203 |
| Atorvastatin | 498 | $6,728 | $14 |
| Vascepa | 17 | $6,118 | $360 |
| Clopidogrel | 383 | $4,620 | $12 |
| Isosorbide Mononitrate Er | 145 | $2,648 | $18 |
| Potassium Chloride | 69 | $2,483 | $36 |
| Rosuvastatin | 41 | $2,453 | $60 |
| Losartan | 243 | $2,327 | $10 |
| Amlodipine Besylate | 398 | $2,151 | $5 |
| Midodrine | 17 | $2,040 | $120 |
| Carvedilol | 222 | $1,976 | $9 |
| Prasugrel | 20 | $1,780 | $89 |
| Losartan-Hydrochlorothiazide | 16 | $1,555 | $97 |
| Lisinopril | 242 | $1,489 | $6 |
| Diltiazem 24hr Er | 21 | $1,358 | $65 |
| Diltiazem 24hr Er (Cd) | 19 | $1,254 | $66 |
| Furosemide | 271 | $1,239 | $5 |
| Valsartan-Hydrochlorothiazide | 22 | $1,236 | $56 |
| Bumetanide | 29 | $1,156 | $40 |
| Hydralazine | 54 | $1,072 | $20 |
| Nitroglycerin | 42 | $906 | $22 |
| Amiodarone | 54 | $905 | $17 |
| Spironolactone | 119 | $819 | $7 |
| Valsartan | 15 | $765 | $51 |
| Metoprolol | 136 | $747 | $5 |
| Nifedipine Er | 17 | $476 | $28 |
| Digoxin | 16 | $450 | $28 |
| Simvastatin | 46 | $444 | $10 |
| Cartia Xt | 12 | $365 | $30 |
| Olmesartan Medoxomil | 11 | $352 | $32 |
| Irbesartan-Hydrochlorothiazide | 12 | $306 | $25 |
| Cilostazol | 11 | $268 | $24 |
| Propranolol | 11 | $259 | $24 |
| Pantoprazole | 23 | $219 | $10 |
| Hydrochlorothiazide | 47 | $213 | $5 |
| Enalapril Maleate | 12 | $199 | $17 |
| Atenolol | 16 | $152 | $10 |
| Lisinopril-Hydrochlorothiazide | 20 | $133 | $7 |
| Benazepril | 11 | $129 | $12 |
| Allopurinol | 11 | $106 | $10 |
| Diazepam | 19 | $37 | $2 |
2019: 45 drugs
| Eliquis | 318 | $160,426 | $504 |
| Brilinta | 94 | $46,683 | $497 |
| Xarelto | 72 | $42,509 | $590 |
| Repatha Sureclick | 19 | $28,067 | $1,477 |
| Metoprolol | 1,154 | $23,407 | $20 |
| Pradaxa | 24 | $17,728 | $739 |
| Entresto | 15 | $11,137 | $742 |
| Atorvastatin | 495 | $6,994 | $14 |
| Ranolazine Er | 21 | $5,451 | $260 |
| Clopidogrel | 436 | $5,113 | $12 |
| Diltiazem 24hr Er (Cd) | 27 | $3,225 | $119 |
| Vascepa | 11 | $2,530 | $230 |
| Isosorbide Mononitrate Er | 162 | $2,510 | $15 |
| Amlodipine Besylate | 433 | $2,416 | $6 |
| Rosuvastatin | 40 | $2,263 | $57 |
| Carvedilol | 272 | $2,125 | $8 |
| Lisinopril | 366 | $2,121 | $6 |
| Prasugrel | 24 | $2,050 | $85 |
| Furosemide | 368 | $1,632 | $4 |
| Losartan | 219 | $1,540 | $7 |
| Bumetanide | 43 | $1,508 | $35 |
| Amiodarone | 81 | $1,267 | $16 |
| Potassium Chloride | 62 | $1,168 | $19 |
| Diltiazem 24hr Er | 33 | $1,085 | $33 |
| Hydralazine | 60 | $1,066 | $18 |
| Olmesartan Medoxomil | 14 | $1,024 | $73 |
| Nitroglycerin | 52 | $1,020 | $20 |
| Midodrine | 16 | $995 | $62 |
| Valsartan | 20 | $934 | $47 |
| Metoprolol | 109 | $786 | $7 |
| Cartia Xt | 18 | $524 | $29 |
| Simvastatin | 59 | $523 | $9 |
| Spironolactone | 105 | $522 | $5 |
| Metolazone | 12 | $503 | $42 |
| Propranolol | 12 | $395 | $33 |
| Cilostazol | 22 | $346 | $16 |
| Losartan-Hydrochlorothiazide | 25 | $291 | $12 |
| Benazepril | 40 | $259 | $6 |
| Hydrochlorothiazide | 51 | $243 | $5 |
| Pantoprazole | 32 | $240 | $7 |
| Irbesartan | 15 | $237 | $16 |
| Atenolol | 18 | $219 | $12 |
| Pravastatin | 12 | $177 | $15 |
| Clonidine | 22 | $104 | $5 |
| Lisinopril-Hydrochlorothiazide | 15 | $104 | $7 |
2018: 34 drugs
| Eliquis | 171 | $86,899 | $508 |
| Brilinta | 119 | $42,632 | $358 |
| Ranexa | 43 | $19,240 | $447 |
| Pradaxa | 28 | $17,796 | $636 |
| Metoprolol | 874 | $15,948 | $18 |
| Xarelto | 21 | $11,941 | $569 |
| Prasugrel | 32 | $9,066 | $283 |
| Atorvastatin | 326 | $4,946 | $15 |
| Diltiazem 24hr Er (Cd) | 33 | $2,291 | $69 |
| Bumetanide | 39 | $2,042 | $52 |
| Clopidogrel | 195 | $1,936 | $10 |
| Amiodarone | 60 | $1,866 | $31 |
| Isosorbide Mononitrate Er | 110 | $1,742 | $16 |
| Amlodipine Besylate | 332 | $1,732 | $5 |
| Carvedilol | 244 | $1,623 | $7 |
| Lisinopril | 271 | $1,350 | $5 |
| Losartan | 146 | $980 | $7 |
| Rosuvastatin | 12 | $876 | $73 |
| Potassium Chloride | 41 | $816 | $20 |
| Furosemide | 204 | $813 | $4 |
| Digitek | 18 | $713 | $40 |
| Metoprolol | 130 | $660 | $5 |
| Nitroglycerin | 15 | $469 | $31 |
| Spironolactone | 70 | $385 | $5 |
| Cilostazol | 32 | $376 | $12 |
| Atenolol | 36 | $334 | $9 |
| Simvastatin | 45 | $301 | $7 |
| Hydralazine | 25 | $300 | $12 |
| Valsartan | 17 | $262 | $15 |
| Pantoprazole | 18 | $201 | $11 |
| Benazepril | 24 | $191 | $8 |
| Irbesartan | 14 | $177 | $13 |
| Hydrochlorothiazide | 47 | $169 | $4 |
| Famotidine | 11 | $79 | $7 |
2017: 33 drugs
| Eliquis | 78 | $35,220 | $452 |
| Effient | 64 | $30,415 | $475 |
| Ranexa | 42 | $17,747 | $423 |
| Xarelto | 33 | $17,184 | $521 |
| Pradaxa | 38 | $14,258 | $375 |
| Brilinta | 31 | $10,495 | $339 |
| Metoprolol | 537 | $10,494 | $20 |
| Prasugrel | 17 | $6,166 | $363 |
| Atorvastatin | 241 | $3,155 | $13 |
| Amiodarone | 19 | $2,419 | $127 |
| Isosorbide Mononitrate Er | 125 | $1,815 | $15 |
| Clopidogrel | 144 | $1,398 | $10 |
| Lisinopril | 257 | $1,214 | $5 |
| Carvedilol | 212 | $1,188 | $6 |
| Digoxin | 18 | $996 | $55 |
| Bumetanide | 29 | $983 | $34 |
| Digox | 24 | $951 | $40 |
| Amlodipine Besylate | 204 | $821 | $4 |
| Furosemide | 176 | $594 | $3 |
| Potassium Chloride | 24 | $586 | $24 |
| Isosorbide Dinitrate | 13 | $539 | $41 |
| Cilostazol | 22 | $505 | $23 |
| Metoprolol | 97 | $439 | $5 |
| Nitroglycerin | 12 | $322 | $27 |
| Hydralazine | 38 | $289 | $8 |
| Spironolactone | 37 | $237 | $6 |
| Simvastatin | 44 | $234 | $5 |
| Valsartan | 14 | $215 | $15 |
| Benazepril | 26 | $189 | $7 |
| Losartan | 24 | $163 | $7 |
| Atenolol | 38 | $148 | $4 |
| Diltiazem 24hr Er | 17 | $145 | $9 |
| Hydrochlorothiazide | 36 | $129 | $4 |
2016: 33 drugs
| Eliquis | 82 | $34,120 | $416 |
| Effient | 46 | $23,465 | $510 |
| Ranexa | 50 | $20,423 | $408 |
| Xarelto | 44 | $19,070 | $433 |
| Pradaxa | 33 | $11,401 | $345 |
| Metoprolol | 505 | $9,313 | $18 |
| Atorvastatin | 217 | $2,965 | $14 |
| Isosorbide Mononitrate Er | 188 | $2,685 | $14 |
| Clopidogrel | 175 | $1,860 | $11 |
| Digoxin | 26 | $1,372 | $53 |
| Amlodipine Besylate | 239 | $1,326 | $6 |
| Carvedilol | 193 | $1,224 | $6 |
| Lisinopril | 231 | $1,158 | $5 |
| Digox | 33 | $1,045 | $32 |
| Potassium Chloride | 38 | $956 | $25 |
| Metolazone | 26 | $877 | $34 |
| Amiodarone | 17 | $782 | $46 |
| Furosemide | 189 | $743 | $4 |
| Cilostazol | 29 | $416 | $14 |
| Valsartan | 24 | $412 | $17 |
| Metoprolol | 84 | $367 | $4 |
| Losartan | 65 | $346 | $5 |
| Bumetanide | 17 | $307 | $18 |
| Isosorbide Dinitrate | 11 | $297 | $27 |
| Spironolactone | 46 | $292 | $6 |
| Hydralazine | 22 | $253 | $11 |
| Valsartan-Hydrochlorothiazide | 11 | $244 | $22 |
| Warfarin | 11 | $199 | $18 |
| Hydrochlorothiazide | 54 | $178 | $3 |
| Benazepril | 30 | $164 | $5 |
| Famotidine | 22 | $137 | $6 |
| Atenolol | 18 | $92 | $5 |
| Simvastatin | 13 | $84 | $6 |
2015: 37 drugs
| Xarelto | 45 | $21,063 | $468 |
| Ranexa | 45 | $14,510 | $322 |
| Pradaxa | 36 | $13,892 | $386 |
| Eliquis | 33 | $13,374 | $405 |
| Effient | 28 | $11,148 | $398 |
| Metoprolol | 507 | $9,366 | $18 |
| Isosorbide Mononitrate Er | 258 | $3,282 | $13 |
| Tribenzor | 12 | $2,721 | $227 |
| Crestor | 12 | $2,548 | $212 |
| Atorvastatin | 208 | $2,434 | $12 |
| Digoxin | 44 | $2,206 | $50 |
| Clopidogrel | 237 | $2,033 | $9 |
| Valsartan | 44 | $1,906 | $43 |
| Amiodarone | 58 | $1,673 | $29 |
| Amlodipine Besylate | 286 | $1,353 | $5 |
| Hydralazine | 48 | $1,298 | $27 |
| Carvedilol | 194 | $1,283 | $7 |
| Lisinopril | 234 | $936 | $4 |
| Potassium Chloride | 23 | $816 | $35 |
| Metolazone | 23 | $704 | $31 |
| Metoprolol | 137 | $697 | $5 |
| Furosemide | 154 | $629 | $4 |
| Cilostazol | 31 | $553 | $18 |
| Warfarin | 35 | $504 | $14 |
| Hydrochlorothiazide | 98 | $486 | $5 |
| Isosorbide Dinitrate | 12 | $363 | $30 |
| Enalapril Maleate | 12 | $343 | $29 |
| Losartan | 47 | $336 | $7 |
| Digitek | 11 | $333 | $30 |
| Spironolactone | 40 | $269 | $7 |
| Famotidine | 26 | $172 | $7 |
| Doxazosin Mesylate | 11 | $163 | $15 |
| Atenolol | 33 | $156 | $5 |
| Benazepril | 23 | $133 | $6 |
| Simvastatin | 24 | $115 | $5 |
| Pantoprazole | 17 | $110 | $6 |
| Triamterene-Hydrochlorothiazid | 12 | $71 | $6 |
2014: 31 drugs
| Xarelto | 39 | $14,358 | $368 |
| Pradaxa | 32 | $13,366 | $418 |
| Metoprolol | 493 | $11,522 | $23 |
| Atorvastatin | 190 | $3,112 | $16 |
| Diovan | 22 | $2,969 | $135 |
| Clopidogrel | 186 | $2,717 | $15 |
| Isosorbide Mononitrate Er | 200 | $2,492 | $12 |
| Tribenzor | 12 | $2,261 | $188 |
| Crestor | 12 | $2,229 | $186 |
| Carvedilol | 184 | $1,644 | $9 |
| Digoxin | 27 | $1,349 | $50 |
| Lisinopril | 230 | $1,245 | $5 |
| Amlodipine Besylate | 167 | $981 | $6 |
| Hydralazine | 38 | $959 | $25 |
| Cilostazol | 42 | $796 | $19 |
| Metoprolol | 104 | $733 | $7 |
| Amiodarone | 36 | $618 | $17 |
| Furosemide | 142 | $603 | $4 |
| Warfarin | 40 | $370 | $9 |
| Spironolactone | 40 | $329 | $8 |
| Simvastatin | 36 | $316 | $9 |
| Isosorbide Dinitrate | 11 | $308 | $28 |
| Nitrostat | 14 | $285 | $20 |
| Enalapril Maleate | 11 | $266 | $24 |
| Hydrochlorothiazide | 46 | $249 | $5 |
| Metolazone | 11 | $224 | $20 |
| Losartan | 27 | $223 | $8 |
| Lovastatin | 11 | $138 | $13 |
| Famotidine | 27 | $137 | $5 |
| Atenolol | 21 | $101 | $5 |
| Pantoprazole | 15 | $87 | $6 |
2013: 26 drugs
| Metoprolol | 297 | $7,759 | $26 |
| Xarelto | 14 | $4,784 | $342 |
| Pradaxa | 15 | $4,535 | $302 |
| Crestor | 19 | $3,301 | $174 |
| Atorvastatin | 138 | $3,223 | $23 |
| Nexium | 14 | $3,031 | $217 |
| Clopidogrel | 97 | $2,859 | $29 |
| Carvedilol | 102 | $1,257 | $12 |
| Isosorbide Mononitrate Er | 84 | $1,089 | $13 |
| Amlodipine Besylate | 110 | $803 | $7 |
| Lisinopril | 126 | $607 | $5 |
| Furosemide | 135 | $569 | $4 |
| Cilostazol | 25 | $483 | $19 |
| Warfarin | 36 | $412 | $11 |
| Propafenone | 12 | $360 | $30 |
| Metoprolol | 46 | $310 | $7 |
| Amiodarone | 11 | $249 | $23 |
| Simvastatin | 35 | $249 | $7 |
| Losartan | 22 | $239 | $11 |
| Diltiazem 24hr Cd | 15 | $231 | $15 |
| Nitrostat | 14 | $220 | $16 |
| Digox | 18 | $218 | $12 |
| Hydralazine | 17 | $172 | $10 |
| Enalapril Maleate | 12 | $141 | $12 |
| Hydrochlorothiazide | 22 | $135 | $6 |
| Pantoprazole | 15 | $126 | $8 |
Money from drug and device companies
$576 in 2025
| 2025 | 4 | 24 | None | $576 |
| 2024 | 8 | 37 | None | $3,136 |
| 2023 | 5 | 31 | None | $876 |
| 2022 | 4 | 6 | None | $66 |
| 2021 | 7 | 36 | None | $1,148 |
| 2020 | 6 | 26 | None | $964 |
| 2019 | 13 | 86 | None | $1,518 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Navitor | $243 | 3 payments
|
| Amgen | Repatha | $155 | 18 payments
|
| Abiomed | None | $143 | 1 payment
|
| Pfizer | Eliquis | $34 | 2 payments
|
See all 24 published payments
| Abbott Laboratories | Meals · 2025-12-24 | Aveir | $48 |
| Amgen | Meals · 2025-12-19 | Repatha | $8 |
| Abiomed | Meals · 2025-12-05 | None | $143 |
| Amgen | Meals · 2025-12-03 | Repatha | $12 |
| Amgen | Meals · 2025-11-20 | Repatha | $10 |
| Amgen | Meals · 2025-11-05 | Repatha | $10 |
| Amgen | Meals · 2025-10-30 | Repatha | $7 |
| Amgen | Meals · 2025-10-22 | Repatha | $10 |
| Amgen | Meals · 2025-09-29 | Repatha | $10 |
| Amgen | Meals · 2025-09-16 | Repatha | $7 |
| Amgen | Meals · 2025-08-22 | Repatha | $9 |
| Pfizer | Meals · 2025-08-20 | Eliquis | $19 |
| Amgen | Meals · 2025-07-24 | Repatha | $10 |
| Abbott Laboratories | Meals · 2025-07-11 | Merlin@Home | $14 |
| Amgen | Meals · 2025-06-13 | Repatha | $7 |
| Amgen | Meals · 2025-05-28 | Repatha | $4 |
| Abbott Laboratories | Meals · 2025-05-06 | Navitor | $181 |
| Amgen | Meals · 2025-04-21 | Repatha | $9 |
| Amgen | Meals · 2025-03-21 | Repatha | $15 |
| Amgen | Meals · 2025-03-14 | Repatha | $5 |
| Amgen | Meals · 2025-03-13 | Repatha | $9 |
| Amgen | Meals · 2025-02-03 | Repatha | $5 |
| Pfizer | Meals · 2025-01-14 | Eliquis | $15 |
| Amgen | Meals · 2025-01-13 | Repatha | $8 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,136
| Abbott Laboratories | Optis | $2,567 | 15 payments
|
| Amgen | Repatha | $302 | 14 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $124 | 1 payment
|
| Medtronic | Venaseal | $43 | 2 payments
|
| Pfizer | Eliquis | $33 | 2 payments
|
| Tactile Systems Technology | Flexitouch Plus | $25 | 1 payment
|
| Abiomed | Impella | $23 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $19 | 1 payment
|
2023: $876
| Amgen | Repatha | $534 | 23 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $152 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $110 | 1 payment
|
| Abbott Laboratories | Xience Skypoint | $65 | 4 payments
|
| Pfizer | Eliquis | $15 | 1 payment
|
2022: $66
| Cardiovascular Systems | Diamondback Peripheral | $20 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $20 | 1 payment
|
| Medtronic | Avalus | $14 | 1 payment
|
| Amgen | Repatha | $12 | 1 payment
|
2021: $1,148
| Abbott Laboratories | Mitraclip System | $425 | 8 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $278 | 5 payments
|
| Amgen | Repatha | $241 | 18 payments
|
| Medtronic | Corevalve Evolut | $143 | 2 payments
|
| Shockwave Medical | Vascular Lithotripsy | $23 | 1 payment
|
| Abiomed | Impella | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $18 | 1 payment
|
2020: $964
| Cardiovascular Systems | Peripheral Orbital Atherectomy System | $421 | 6 payments
|
| Medtronic Vascular | 3f | $315 | 5 payments
|
| Amgen | Repatha | $111 | 10 payments
|
| Abbott Laboratories | Absolute Pro Vascular Stent System | $52 | 3 payments
|
| Boston Scientific | Rotablator | $48 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $17 | 1 payment
|
2019: $1,518
| Amgen | Repatha | $866 | 54 payments
|
| Novartis Pharmaceuticals | Entresto | $179 | 11 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $139 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $69 | 4 payments
|
| Bard Peripheral Vascular | Lutonix | $59 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $50 | 3 payments
|
| Pfizer | Eliquis | $46 | 2 payments
|
| Abiomed | Impella | $25 | 1 payment
|
| Sanofi-Aventis U.S. | Praluent | $24 | 1 payment
|
| Abbott Laboratories | Heartmate | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $17 | 1 payment
|
| Amarin Pharma | Vascepa | $16 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1154521540
- Licence
- CA A100025California A100025: Current · expires 2026-12-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 0A1000250
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 1313 E Herndon Ave, Suite 203, Fresno, CA, 93720
- NPI first listed
- 2007-07-23
- NPI last updated
- 2017-02-28
This is when the NPI record was last certified, not a medical board exam.